Výsledky vyhledávání - "F. W. Cervenko"

Arterial isoflurane concentration and EEG burst suppression during cardiopulmonary bypass

Autor: Graeme D. Johnson, Donald G. Brunet, Christopher W. Loomis, F. W. Cervenko, Brian Milne

Publikováno v: Clinical Pharmacology and Therapeutics. 40:304-313

Isoflurane (1.5 to 3.0 vol% in oxygen) was used to control intraoperative hypertension in 10 patients undergoing hypothermic cardiopulmonary bypass surgery. Isoflurane was administered through the membrane oxygenator of the bypass pump and yielded pl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc91781e98c2d18a3c68062da466d3d2
https://doi.org/10.1038/clpt.1986.181

Zobrazit plný text záznamu

Effects of naloxone on exercise performance

Autor: G. M. Andrew, P. P. Hamilton, G. D. Surbey, F. W. Cervenko

Publikováno v: Journal of Applied Physiology. 57:674-679

This study was designed to investigate the effects of naloxone on athletic performance in humans. Two groups of elite middle-distance runners performed a maximal or a submaximal exercise protocol following the double-blind intravenous injection of ei

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e99b37c568b0ed2fce0d97d7e7f62e4f
https://doi.org/10.1152/jappl.1984.57.3.674

Zobrazit plný text záznamu

Abstracts

Autor: H. T. Kieraszewicz, A. M. Lam, D. J. Steward, G. A. Volgyesi, K. G. Smedstead, A. C. P. Powles, G. L. Wolf, C. Capuano, D. Chartrand, J. Couture, C. P. Cole, F. Donatī, J. G. Maillé, A. Roof, R. Blain, G. A. Finley, M. Cherry, D. Cotton, J. F. Nicholas, D. Petkau, J. D. Kettner, J. G. Ramsay, G. E. Townsend, R. Martin, J. P. Tétrault, L. Tétreault, Y. Lamarche, L. J. Veilleux, A. W. Gotta, S. Carsons, L. Abrams, C. Sullivan, M. E. Futter, D. R. Whalley, J. E. Wynands, D. R. Bevan, M. Ghignone, R. M. Prewitt, M. Razen, L. Girling, L. Slykerman, J. C. Kay, W. H. Noble, J. B. Forrest, C. Chambers, R. Kozody, F. Cheney, F. Carli, B. D. Higgs, R. L. Knill, W. R. Thompson, J. L. Clement, G. P. Varkey, W. E. Spoerel, J. A. Moffat, M. McDougall, D. Spence, F. Saunders, E. S. Shelley, F. W. Cervenko, D. Brunet, B. Milne, P. W. Harris, D. H. Morison, G. L. Dunn, A. M. Fargas-Babjak, G. C. Moudgil, K. Smedsted, J. Woo, J. G. Williams, L. Strunin, S. Ward, D. Wright, I. Corall, E. A. M. Neill, J. Marty, J. Champlain, J. P. Kenefick, S. Roth, K. Jhamandas, C. T. Hemmings, S. K. Weeks, J. B. Smith, B. Y. Ong, W. A. Tweed, R. Yarnell, D. S. Sitar, M. E. McLeod, L. Roy, K. J. Bennett

Publikováno v: Canadian Anaesthetists’ Society Journal. 30:S62-S87

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8ec6c09fa349385ab7ccfeb295324ee3
https://doi.org/10.1007/bf03009982

Zobrazit plný text záznamu

Prolonged QT interval syndromes

Autor: F W, Cervenko

Publikováno v: Anesthesia and analgesia. 65(2)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9c0cc4ee0a762b14f1255aa82568d0d2
https://pubmed.ncbi.nlm.nih.gov/2867720

Zobrazit plný text záznamu

Intrathecal clonidine: analgesia and effect on opiate withdrawal in the rat

Autor: B, Milne, F W, Cervenko, K, Jhamandas, M, Sutak

Publikováno v: Anesthesiology. 62(1)

Clonidine, an alpha 2 adrenergic agonist, has analgesic properties and recently has been used to suppress opiate withdrawal. These two properties theoretically make it a suitable analgesic substitute in patients tolerant to opioids. The objectives of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9f9759845a834902a6dc23e73143dc2c
https://pubmed.ncbi.nlm.nih.gov/4038443

Zobrazit plný text záznamu

Tolerance to intrathecal oxymetazoline-induced analgesia, with paradigm-dependent cross-tolerance to intrathecal morphine

Autor: S E, Sherman, C W, Loomis, B, Milne, F W, Cervenko

Publikováno v: The Journal of pharmacology and experimental therapeutics. 245(1)

Male, Sprague-Dawley rats, implanted with intrathecal (i.t.) catheters, were given repeated i.t. injections of morphine (40 nmol), oxymetazoline (100 nmol) or saline (10 microliter) at 12-h intervals for 3 days. Antinociception was determined 1 or 1.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cfad73cc7fb3b13d330b66eacfc071e8
https://pubmed.ncbi.nlm.nih.gov/3361450

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání